O
OrbiMed’s Theravance Biopharma TBPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,370,250
| Closed | -$12.4K | – | 140 |
|
|
2022
Q2 | $12.4K | Sell |
1,370,250
-1,884,463
| -58% | -$17.1K | 0.22% | 82 |
|
|
2022
Q1 | $31.1M | Sell |
3,254,713
-2,719,822
| -46% | -$26M | 0.5% | 52 |
|
|
2021
Q4 | $66M | Buy |
5,974,535
+79,376
| +1% | +$877K | 0.85% | 41 |
|
|
2021
Q3 | $43.6M | Buy |
5,895,159
+1,331,114
| +29% | +$9.85M | 0.48% | 58 |
|
|
2021
Q2 | $66.3M | Sell |
4,564,045
-1,655,065
| -27% | -$24M | 0.67% | 47 |
|
|
2021
Q1 | $127M | Hold |
6,219,110
| – | – | 1.19% | 23 |
|
|
2020
Q4 | $111M | Hold |
6,219,110
| – | – | 0.97% | 29 |
|
|
2020
Q3 | $92M | Buy |
6,219,110
+3,664,640
| +143% | +$54.2M | 1.16% | 25 |
|
|
2020
Q2 | $53.6M | Buy |
2,554,470
+2,342,925
| +1,108% | +$49.2M | 0.75% | 43 |
|
|
2020
Q1 | $4.89M | Buy |
+211,545
| New | +$4.89M | 0.08% | 104 |
|